is an Indian startup company (DIPP 29327) and having a DSIR recognized Research and Development Centre in New Delhi India. Ruhvenile is known for its ability to develop indigenous products through research and development with its own national international experienced scientific strength. Ruhvenile has received several grants including BIRAC-BIG , BIRAC-GG grants and established international and national collaborations to develop novel products to fulfil the unmet needs of our society. Ruhvenile has also received NIDHI4COVID2.0, NIDHIPrayas and EIR grants from Department of Science and Technology, Government of India for its innovative work and and one of the innovation has been recognized as a national importance to combat present. and future pandemic.Ruhvenile has a Research and Development Centre in New Delhi that has been recognized by Department of Scientific ad Industrial Research (DSIR), Government of India. BiomLife® is the first-of-its-kind product in India, and possibly the world, that serves as a universal transport liquid media suitable for a wide range of microbiological samples, including SKIN, GUT, FECAL, ORAL, VAGINAL, LIVER, BRAIN,
Health and social work
Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.
Extracted from Ruhvenile Biomedical (OPC) Private Limited's own website, fetched Jul 2026. Verification badges reflect format/MX checks, not endorsement.